http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112359118-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112359118-B |
titleOfInvention | Application of long-chain non-coding RNA AC073352.1 as breast cancer diagnosis marker and treatment target |
abstract | The invention belongs to the technical field of biological medicines, and relates to application of a long-chain non-coding RNA lncRNA AC073352.1 in breast cancer diagnosis biomarkers and treatment targets. The lncRNA AC073352.1 can be used as a biomarker for breast cancer diagnosis and a drug therapy target for the first time. lncRNA AC073352.1 was significantly upregulated in the serum of breast cancer patients. lncRNA AC073352.1 has good ability to diagnose breast cancer. The result of the invention shows that the lncRNA AC073352.1 exists in both cytoplasm and nucleus of the breast cancer, and the interference of lncRNA AC073352.1 can inhibit the migration and invasion of the breast cancer cells, so that the lncRNA AC073352.1 plays a role of a cancer-promoting gene in the occurrence and development of the breast cancer, and provides a new target point for clinical treatment of the breast cancer. |
priorityDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.